EP Patent

EP4613282A1 — Cyclic peptide derivative composition for treating or preventing central nervous system injury/disease

Assigned to DKS Co Ltd · Expires 2025-09-10 · 1y expired

What this patent protects

The present disclosure provides a cyclic peptide derivative composition for treating or preventing central nervous system injured diseases. The present disclosure relates to a composition comprising a compound for treating or preventing a central nervous system injured dise…

USPTO Abstract

The present disclosure provides a cyclic peptide derivative composition for treating or preventing central nervous system injured diseases. The present disclosure relates to a composition comprising a compound for treating or preventing a central nervous system injured disease or a pharmaceutically acceptable salt, solvate or prodrug thereof. More specifically, the composition of the present disclosure can treat or prevent atherosclerotic cerebral infarction, cardiogenic cerebral infarction or lacunar infarction. The technology provided by the present disclosure can be used for a cyclic peptide derivative for modulating nervous system cell activity and a method for producing said cyclic peptide derivative.

Drugs covered by this patent

Patent Metadata

Patent number
EP4613282A1
Jurisdiction
EP
Classification
Expires
2025-09-10
Drug substance claim
No
Drug product claim
No
Assignee
DKS Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.